Improvement of tardive dyskinesia in a depressive patient treated with fluvoxamine
Introduction Depressive patients often receive antipsyhotics as ad-on treatmnent due to different reasons. Rare side effect, but with high potential for chronicity is tadrive dyskinesia. Standart treatment of this incapacitating condition includes tetrabenasine, valbenasine (not available in Bulgar...
Main Author: | G. Dzhupanov |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823004376/type/journal_article |
Similar Items
-
Improvement of Tardive Dyskinesias with Olanzapine
by: S. Echater, et al.
Published: (2023-01-01) -
Tardive Dyskinesia and Treatment Approaches
by: Mehmet Emin Demirkol, et al.
Published: (2018-06-01) -
Drug-induced tardive dyskinesia
by: T. M. Ostroumova, et al.
Published: (2020-02-01) -
Improvement of Tardive Dyskinesia during Mindfulness Meditation
by: Maria Angela Santoro, et al.
Published: (2021-08-01) -
The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
by: Robert H. Farber, et al.
Published: (2024-01-01)